Influence of Microfiltered-seawater Supplementation and Variable Resistance Training in Blood Pressure, Oxidative Stress, Hepatic, and Renal Biomarkers in Older Women

NCT06600243 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 109

Last updated 2024-09-23

No results posted yet for this study

Summary

This study was conducted to investigate the effects of the intake of deep sea water prior to resistance training on blood pressure, oxidative stress and hepatic and renal variables in older women.

Conditions

  • Blood Pressure
  • Oxidative Stress
  • Renal Disease
  • Hepatic Impairment

Interventions

DIETARY_SUPPLEMENT

Resistance training + deep sea water

A group that will perform a resistance training protocol with variable resistance and at the same time will receive a supplementation composed by deep sea water

DIETARY_SUPPLEMENT

Resistance training + Placebo

A group that will perform a resistance training protocol with variable resistance and at the same time will receive a placebo supplementation that have the same tasted than the deep sea water supplementation

DIETARY_SUPPLEMENT

Control + deep sea water

A group that will maintain their usual live and at the same time will receive a supplementation composed by deep sea water

DIETARY_SUPPLEMENT

Control + Placebo

A group that will maintain their usual live and at the same time will receive a placebo supplementation that have the same tasted than the deep sea water supplementation

Sponsors & Collaborators

  • University of Valencia

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-05-31
Primary Completion
2015-07-31
Completion
2015-07-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06600243 on ClinicalTrials.gov